A prospective study of changes in anxiety, depression, and problems in living during chemotherapy treatments: effects of age and gender

Cristiane Decat Bergerot, Hannah Rose Mitchell, Kimlin Tam Ashing, Youngmee Kim

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Purpose: Monitoring distress assessment in cancer patients during the treatment phase is a component of good quality care practice. Yet, there is a dearth of prospective studies examining distress. In an attempt to begin filling this gap and inform clinical practice, we conducted a prospective, longitudinal study examining changes in distress (anxiety, depression, and problems in living) by age and gender and the roles of age and gender in predicting distress. Methods: Newly diagnosed Brazilian cancer patients (N = 548) were assessed at three time points during chemotherapy. Age and gender were identified on the first day of chemotherapy (T1); anxiety, depression, and problems in living were self-reported at T1, the planned midway point (T2), and the last day of chemotherapy (T3). Results: At T1, 37 and 17% of patients reported clinically significant levels of anxiety and depression, respectively. At T3, the prevalence was reduced to 4.6% for anxiety and 5.1% for depression (p < .001). Patients 40–55 years, across all time points, reported greater anxiety and practical problems than patients >70 years (p < .03). Female patients reported greater emotional, physical, and family problems than their male counterparts (p < .04). Conclusions: For most patients, elevated levels of distress noted in the beginning of treatment subsided by the time of treatment completion. However, middle-aged and female patients continued to report heightened distress. Evidence-based psychosocial intervention offered to at risk patients during early phases of the treatment may provide distress relief and improve outcomes over the illness trajectory while preventing psychosocial and physical morbidity due to untreated chronic distress.

Original languageEnglish (US)
Pages (from-to)1-8
Number of pages8
JournalSupportive Care in Cancer
DOIs
StateAccepted/In press - Feb 2 2017

Fingerprint

Anxiety
Prospective Studies
Depression
Drug Therapy
Therapeutics
Quality of Health Care
Longitudinal Studies
Neoplasms
Morbidity

Keywords

  • Age
  • Anxiety
  • Brazilian cancer patients
  • Depression
  • Gender
  • Longitudinal study
  • Problems in living

ASJC Scopus subject areas

  • Oncology

Cite this

A prospective study of changes in anxiety, depression, and problems in living during chemotherapy treatments : effects of age and gender. / Bergerot, Cristiane Decat; Mitchell, Hannah Rose; Ashing, Kimlin Tam; Kim, Youngmee.

In: Supportive Care in Cancer, 02.02.2017, p. 1-8.

Research output: Contribution to journalArticle

@article{4bc0e6bf3c874ef4bcea15cfe73abb97,
title = "A prospective study of changes in anxiety, depression, and problems in living during chemotherapy treatments: effects of age and gender",
abstract = "Purpose: Monitoring distress assessment in cancer patients during the treatment phase is a component of good quality care practice. Yet, there is a dearth of prospective studies examining distress. In an attempt to begin filling this gap and inform clinical practice, we conducted a prospective, longitudinal study examining changes in distress (anxiety, depression, and problems in living) by age and gender and the roles of age and gender in predicting distress. Methods: Newly diagnosed Brazilian cancer patients (N = 548) were assessed at three time points during chemotherapy. Age and gender were identified on the first day of chemotherapy (T1); anxiety, depression, and problems in living were self-reported at T1, the planned midway point (T2), and the last day of chemotherapy (T3). Results: At T1, 37 and 17{\%} of patients reported clinically significant levels of anxiety and depression, respectively. At T3, the prevalence was reduced to 4.6{\%} for anxiety and 5.1{\%} for depression (p < .001). Patients 40–55 years, across all time points, reported greater anxiety and practical problems than patients >70 years (p < .03). Female patients reported greater emotional, physical, and family problems than their male counterparts (p < .04). Conclusions: For most patients, elevated levels of distress noted in the beginning of treatment subsided by the time of treatment completion. However, middle-aged and female patients continued to report heightened distress. Evidence-based psychosocial intervention offered to at risk patients during early phases of the treatment may provide distress relief and improve outcomes over the illness trajectory while preventing psychosocial and physical morbidity due to untreated chronic distress.",
keywords = "Age, Anxiety, Brazilian cancer patients, Depression, Gender, Longitudinal study, Problems in living",
author = "Bergerot, {Cristiane Decat} and Mitchell, {Hannah Rose} and Ashing, {Kimlin Tam} and Youngmee Kim",
year = "2017",
month = "2",
day = "2",
doi = "10.1007/s00520-017-3596-9",
language = "English (US)",
pages = "1--8",
journal = "Supportive Care in Cancer",
issn = "0941-4355",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - A prospective study of changes in anxiety, depression, and problems in living during chemotherapy treatments

T2 - effects of age and gender

AU - Bergerot, Cristiane Decat

AU - Mitchell, Hannah Rose

AU - Ashing, Kimlin Tam

AU - Kim, Youngmee

PY - 2017/2/2

Y1 - 2017/2/2

N2 - Purpose: Monitoring distress assessment in cancer patients during the treatment phase is a component of good quality care practice. Yet, there is a dearth of prospective studies examining distress. In an attempt to begin filling this gap and inform clinical practice, we conducted a prospective, longitudinal study examining changes in distress (anxiety, depression, and problems in living) by age and gender and the roles of age and gender in predicting distress. Methods: Newly diagnosed Brazilian cancer patients (N = 548) were assessed at three time points during chemotherapy. Age and gender were identified on the first day of chemotherapy (T1); anxiety, depression, and problems in living were self-reported at T1, the planned midway point (T2), and the last day of chemotherapy (T3). Results: At T1, 37 and 17% of patients reported clinically significant levels of anxiety and depression, respectively. At T3, the prevalence was reduced to 4.6% for anxiety and 5.1% for depression (p < .001). Patients 40–55 years, across all time points, reported greater anxiety and practical problems than patients >70 years (p < .03). Female patients reported greater emotional, physical, and family problems than their male counterparts (p < .04). Conclusions: For most patients, elevated levels of distress noted in the beginning of treatment subsided by the time of treatment completion. However, middle-aged and female patients continued to report heightened distress. Evidence-based psychosocial intervention offered to at risk patients during early phases of the treatment may provide distress relief and improve outcomes over the illness trajectory while preventing psychosocial and physical morbidity due to untreated chronic distress.

AB - Purpose: Monitoring distress assessment in cancer patients during the treatment phase is a component of good quality care practice. Yet, there is a dearth of prospective studies examining distress. In an attempt to begin filling this gap and inform clinical practice, we conducted a prospective, longitudinal study examining changes in distress (anxiety, depression, and problems in living) by age and gender and the roles of age and gender in predicting distress. Methods: Newly diagnosed Brazilian cancer patients (N = 548) were assessed at three time points during chemotherapy. Age and gender were identified on the first day of chemotherapy (T1); anxiety, depression, and problems in living were self-reported at T1, the planned midway point (T2), and the last day of chemotherapy (T3). Results: At T1, 37 and 17% of patients reported clinically significant levels of anxiety and depression, respectively. At T3, the prevalence was reduced to 4.6% for anxiety and 5.1% for depression (p < .001). Patients 40–55 years, across all time points, reported greater anxiety and practical problems than patients >70 years (p < .03). Female patients reported greater emotional, physical, and family problems than their male counterparts (p < .04). Conclusions: For most patients, elevated levels of distress noted in the beginning of treatment subsided by the time of treatment completion. However, middle-aged and female patients continued to report heightened distress. Evidence-based psychosocial intervention offered to at risk patients during early phases of the treatment may provide distress relief and improve outcomes over the illness trajectory while preventing psychosocial and physical morbidity due to untreated chronic distress.

KW - Age

KW - Anxiety

KW - Brazilian cancer patients

KW - Depression

KW - Gender

KW - Longitudinal study

KW - Problems in living

UR - http://www.scopus.com/inward/record.url?scp=85011290971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011290971&partnerID=8YFLogxK

U2 - 10.1007/s00520-017-3596-9

DO - 10.1007/s00520-017-3596-9

M3 - Article

C2 - 28150043

AN - SCOPUS:85011290971

SP - 1

EP - 8

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

SN - 0941-4355

ER -